Hearing aid net unit sales in the United States increased by 6.2% in the third quarter (Q3) compared to the same period last year, according to statistics generated by the Hearing Industries Association (HIA), Washington, DC.
Read More
The future is clouded with unknowns like over-the-counter (OTC) opportunities and advances in implantable devices, but I’m sure that baby-boomer demographics will ensure that there will be plenty of potential hearing aid users who will need our help.
Read More
How to thrive in today’s increasingly competitive hearing healthcare business.
Read More
Overall, the findings of this study demonstrate that the two new CROS/BiCROS systems from Signia—the Pure 312 Nx CROS with Narrow directionality and the Silk Nx CROS—provide a superior solution to the daily listening problems encountered by people with SSD.
Read More
Phonak has convened a select group of hearing healthcare experts who propose an audiologic treatment shift from a site-of-lesion focus to a family-centered care perspective as a means of increasing the value of our services and the uptake of hearing devices.
Read More
To maintain consumer safety while dispensing hearing aids and other hearing amplification devices when licensed providers are not involved, a multidisciplinary research team developed the Consumer Ear Disease Risk Assessment (CEDRA) questionnaire, which is designed to identify the risk of diseases with ear and hearing symptoms.
Read More
A broader appreciation for the unique difficulties faced by many of our patients relative to speech understanding in noise and working memory is critical to tailoring individualized interventions that help them realize the full potential of their residual hearing. At present, the Repeat and Recall Test (RRT) shows promise as an efficient, audiology-based integrative tool of speech-in-noise assessment that includes a more complete understanding of a listener’s experience in a loud speech background at various realistic SNRs.
Read More
“Objective testing showed evidence of a balance disorder that affects the inner ear and a unique pattern of cognitive and behavioral dysfunction,” said Dr Michael E. Hoffer, professor of otolaryngology and neurological surgery. “This cluster of auditory and neurological symptoms, along with associated psychological issues, does not resemble more classic traumatic brain injury (TBI) based on our team’s vast experience in this area.”
Read More
OTC hearing devices are coming, but how should they function and for whom should they be recommended? Drs Ron Leavitt, Ruth Bentler, and Carol Flexer present six case studies showing that people with true moderate hearing loss may not be well served by what has been characterized as a “consumer-decides” model of care.
Read More
Federal prosecutors have recommended prison terms of 15-20 years for former Starkey President Jerry Ruzicka and 7-9 years for former Sonion VP of Sales Jeff Taylor for their role in defrauding Starkey Laboratories of more than $20 million. Sentencing commences for Ruzicka and Taylor on Wednesday, December 19, and a day later for former Starkey CFO Scott Nelson and former Northland Hearing executive Jeff Longtain.
Read More
According to Judith Cooper, PhD—acting director of the NIDCD and director of the NIDCD Division of Scientific Programs who is quoted in the article—NIDCD research is primarily focused on identifying hearing loss genes; determining barriers to treatment and evaluating new “service delivery and screening models,” and the application of cochlear implant technology in the development of “other neural prostheses.”
Read More
According to BIHIMA’s announcement, the “most significant” development is the continued growth in the number of units distributed through the private market in the UK: the number of unit sales increased by 2,756 units (3.5%) from the previous year and by 2,638 (3.3%) from Q2 2018. YTD (year-to-date) unit sales were also up 3.8% from 2017.
Read More
The paper, published in the peer-reviewed monthly journal “Hearing Research,” found that the outer-hair-cell-specific protein prestin, in circulation, may act as a biomarker for sensory hair cell damage and death.
Read More
Now, thanks to the award-winning Oticon Opn™ hearing aids, Santa can hear and fulfill children’s wishes this holiday season.
Read More
With the addition of five new custom styles, including what’s said to be “the smallest hearing aid style Oticon has ever produced,” the expanded Opn family will expand its open sound experience in styles and performance levels to satisfy a wide range of veterans’ hearing needs and preferences.
Read More